Galectin-3 and L1 retrotransposons in human breast carcinomas

Abstract

Galectin-3 is a galactoside binding protein found at elevated levels in a wide variety of neoplastic cells and thought to be involved in cognitive cellular interactions during transformation and metastasis. Previously, we have shown that introduction of human galectin-3 (Mr 31,000) cDNA into the human breast cancer cells BT-549 which are galectin-3 null and non-tumorigenic in nude mice resulted in the establishment of four galectin-3 expressing clones. Three of them acquired tumorigenicity when inoculated in the mammary fat pad of nude mice. Here, we questioned what is the molecular difference between the nude mouse tumorigenic and non-tumorigenic galectin-3 expressing BT-549 cell clones. Differential display analysis and Northern blotting revealed that, unlike the tumorigenic clones, neither the parental cells nor the non-tumorigenic clone expressed a 6.5 Kb transcript. A 607 bp PCR (polymerase chain reaction) product from the differentially displayed mRNA revealed a 93% sequence homology with the human L1 retrotransposon previously suggested to play a role in the pathobiology of some breast cancers. In addition, we show that the two gene products, i.e., galectin-3 and L1, are co-expressed in breast carcinoma specimens and in other nude mouse tumorigenic cell lines.

DOI: 10.1023/A:1005913810250
050100'00'02'04'06'08'10'12'14'16
Citations per Year

306 Citations

Semantic Scholar estimates that this publication has 306 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{NangiaMakker1998Galectin3AL, title={Galectin-3 and L1 retrotransposons in human breast carcinomas}, author={Pratima Nangia-Makker and Rebecca Sarvis and Daniel W. Visscher and Juliet Bailey-Penrod and Avraham Raz and Fazlul H. Sarkar}, journal={Breast Cancer Research and Treatment}, year={1998}, volume={49}, pages={171-183} }